LENSAR, Inc. (NASDAQ: LNSR) is plunging in pre-market trading, with shares down 25 percent following the termination of the merger agreement with Alcon Research.
LENSAR, Inc. and Alcon Research, LLC have mutually agreed to terminate their merger agreement due to anticipated regulatory challenges. LENSAR will retain the $10 million deposit from the agreement.
Despite the termination and the FTC’s opposition, LENSAR’s leadership reaffirmed their focus on expanding the market presence of their ALLY Robotic Cataract Laser System™.
The stock was trading around $7.66 in pre-market activity after closing at $10.26 in the prior session.
 is plunging in pre-market trading, with shares down 25 percent following the termination of the merger agreement with Alcon Research.){kind=link}